Schally A V相关文献与解析，生知库 | 链接生命科学的每一步

Bornstein, S R; Steenblock, C; Chrousos, G P; Schally, A V; Beuschlein, F; Kline, G; Krone, N P; Licinio, J; Wong, M L; Ullmann, E; Ruiz-Babot, G; Boehm, B O; Behrens, A; Brennand, A; Santambrogio, A; Berger, I; Werdermann, M; Sancho, R; Linkermann, A; Lenders, J W; Eisenhofer, G; Andoniadou, C L

细胞生物学

发育与干细胞

干细胞

代谢

发表日期：2019

文献求助收藏

Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch

雄激素通过AMPK-PGC-1α介导的代谢转换来调节前列腺癌细胞的生长。

期刊:Oncogene

影响因子:7.3

doi:10.1038/onc.2013.463

Tennakoon, J B; Shi, Y; Han, J J; Tsouko, E; White, M A; Burns, A R; Zhang, A; Xia, X; Ilkayeva, O R; Xin, L; Ittmann, M M; Rick, F G; Schally, A V; Frigo, D E

Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells

靶向神经肽激素受体的肽类似物对小鼠嗜铬细胞瘤细胞的抗肿瘤作用

期刊:Molecular and Cellular Endocrinology

影响因子:3.6

doi:10.1016/j.mce.2012.12.011

Ziegler, C G; Ullrich, M; Schally, A V; Bergmann, R; Pietzsch, J; Gebauer, L; Gondek, K; Qin, N; Pacak, K; Ehrhart-Bornstein, M; Eisenhofer, G; Bornstein, S R

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers

铃蟾肽拮抗剂抑制人类实验性乳腺癌中的促血管生成因子

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/sj.bjc.6601404

Bajo, A M; Schally, A V; Groot, K; Szepeshazi, K

New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs

基于肽类似物的胃癌、结肠癌和胰腺癌治疗新方法

期刊:Cellular and Molecular Life Sciences

影响因子:6.2

doi:10.1007/s00018-004-3434-3

Schally, A V; Szepeshazi, K; Nagy, A; Comaru-Schally, A M; Halmos, G

Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats

比较促黄体生成素释放激素（LHRH）拮抗剂西曲瑞克和LHRH激动剂曲普瑞林对大鼠垂体LHRH受体基因表达的作用机制

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:9.1

doi:10.1073/pnas.211442598

Kovacs, M; Schally, A V

Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH

促黄体生成素释放激素 (LH-RH) 拮抗剂西曲瑞克通过拮抗内源性 LH-RH 的刺激作用，下调垂体 LH-RH 受体的 mRNA 表达。

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:9.1

doi:10.1073/pnas.98.4.1829

Kovacs, M; Schally, A V; Csernus, B; Rekasi, Z

Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions.

胰腺癌细胞在无血清条件下增殖需要 EGF 受体介导的自分泌途径

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1054/bjoc.2001.1698

Murphy L O, Cluck M W, Lovas S, OtvÃ¶s F, Murphy R F, Schally A V, Permert J, Larsson J, Knezetic J A, Adrian T E

Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

生长激素释放激素和血管活性肠肽拮抗剂对UCI-107卵巢癌细胞生长的抑制作用及致瘤性的降低作用

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s004320100254

Chatzistamou, I; Schally, A V; Varga, J L; Groot, K; Armatis, P; Bajo, A M

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies

含阿霉素14-O-半戊二酸酯的细胞毒性促黄体生成素释放激素偶联物（AN-152）在小鼠和人血清中的体外稳定性：对临床前研究设计的启示

期刊:Proceedings of the National Academy of Sciences of the United States of America

影响因子:9.1

doi:10.1073/pnas.97.2.829

Nagy, A; Plonowski, A; Schally, A V

Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease?

应激诱导干细胞：内分泌、代谢和精神疾病的新视角？

Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch

雄激素通过AMPK-PGC-1α介导的代谢转换来调节前列腺癌细胞的生长。

Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells

靶向神经肽激素受体的肽类似物对小鼠嗜铬细胞瘤细胞的抗肿瘤作用

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers

铃蟾肽拮抗剂抑制人类实验性乳腺癌中的促血管生成因子

New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs

基于肽类似物的胃癌、结肠癌和胰腺癌治疗新方法

Comparison of mechanisms of action of luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix and LHRH agonist triptorelin on the gene expression of pituitary LHRH receptors in rats

比较促黄体生成素释放激素（LHRH）拮抗剂西曲瑞克和LHRH激动剂曲普瑞林对大鼠垂体LHRH受体基因表达的作用机制

Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH

促黄体生成素释放激素 (LH-RH) 拮抗剂西曲瑞克通过拮抗内源性 LH-RH 的刺激作用，下调垂体 LH-RH 受体的 mRNA 表达。

Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions.

胰腺癌细胞在无血清条件下增殖需要 EGF 受体介导的自分泌途径

Inhibition of growth and reduction in tumorigenicity of UCI-107 ovarian cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide

生长激素释放激素和血管活性肠肽拮抗剂对UCI-107卵巢癌细胞生长的抑制作用及致瘤性的降低作用

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies

含阿霉素14-O-半戊二酸酯的细胞毒性促黄体生成素释放激素偶联物（AN-152）在小鼠和人血清中的体外稳定性：对临床前研究设计的启示